Clinical trial

A Study of RAY1225 in Participants With Type 2 Diabetes

NCT06254274

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-02-26

PhasePHASE2

Study timeline

Study start (actual)2024-02-26Date precision: day

Registry last updated2025-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

T2DM (Type 2 Diabetes Mellitus)unresolved

Interventions

RAY1225DRUG

PlaceboDRUG

Sponsors & collaborators

Guangdong Raynovent Biotech Co., Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06254274 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.